The company is a market-oriented, R&D and innovation-driven biomedical enterprise focusing on R&D, production and sales of polypeptide drugs and small molecule chemical drugs. The company is committed to solving technical bottlenecks and optimizing process paths in drug development and production through technological innovation, building a whole industry chain from advanced pharmaceutical intermediates and APIs to formulations to provide high-quality, efficient, green and low-cost pharmaceutical products and services to the global market. The company is a biomedical enterprise focusing on the combination of independent research and development of polypeptide drugs and small molecule chemicals with customized R&D and production. The company's main products include customized product business and self-selected product business.
No Data